v3.26.1
Stockholders' Equity (Tables)
6 Months Ended
Jun. 30, 2026
Stockholders' Equity Note [Abstract]  
Schedule of Stockholders' Equity
Stockholders' equity consists of the following (in millions):
Common stock (1)Additional paid-in capitalRetained deficitAccumulated other comprehensive lossTotal stockholders’ equity
Balance at December 31, 2024$1.7 $2,828.2 $(1,168.7)$(74.4)$1,586.8 
Total comprehensive income— — 43.6 (0.2)43.4 
Stock-based compensation expense— 10.5 — — 10.5 
Proceeds from exercise of stock options and ESPP contributions— 1.1 — — 1.1 
Taxes withheld and paid on employees' share-based payment awards— (0.5)— — (0.5)
Repurchase of common stock— — (78.0)— (78.0)
Common stock dividends ($0.09 per share)
— (15.3)— — (15.3)
Balance at March 31, 2025$1.7 $2,824.0 $(1,203.1)$(74.6)$1,548.0 
Total comprehensive income— — 50.5 4.9 55.4 
Stock-based compensation expense— 9.0 — — 9.0 
Proceeds from exercise of stock options and ESPP contributions— 1.3 — — 1.3 
Repurchase of common stock— — (32.9)— (32.9)
Common stock dividends ($0.09 per share)
— (16.4)— — (16.4)
Balance at June 30, 2025$1.7 $2,817.9 $(1,185.5)$(69.7)$1,564.4 
Common stock (1)Additional
paid-in
capital
Retained
deficit
Accumulated
other
comprehensive
loss
Total
stockholders’
equity
Balance at December 31, 2025$1.7 $2,810.0 $(1,131.7)$(76.7)$1,603.3 
Total comprehensive income— — 58.9 (1.6)57.3 
Stock-based compensation expense— 11.7 — — 11.7 
Proceeds from exercise of stock options and ESPP contributions— 2.5 — — 2.5 
Repurchase of common stock— — (50.0)— (50.0)
Common stock dividends ($0.11 per share)
— (18.0)— — (18.0)
Balance at March 31, 2026$1.7 $2,806.2 $(1,122.8)$(78.3)$1,606.8 
Total comprehensive income— — 113.3 (2.5)110.8 
Stock-based compensation expense— 9.2 — — 9.2 
Proceeds from exercise of stock options and ESPP contributions— 1.0 — — 1.0 
Repurchase of common stock— — (50.1)— (50.1)
Common stock dividends ($0.11 per share)
— (18.6)— — (18.6)
Balance at June 30, 2026$1.7 $2,797.8 $(1,059.6)$(80.8)$1,659.1 
(1)During the three and six months ended June 30, 2026, the Company issued 60,468 and 1,158,270 shares of common stock, upon the exercise of stock options, vesting of restricted stock units and performance stock units, and for other common stock issuances, respectively. During the three and six months ended June 30, 2025, the Company issued 109,796 and 597,933 shares of common stock, upon the exercise of stock options, vesting of restricted stock units and performance stock units, and for other common stock issuances, respectively.